Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

Click for more information

0.00%

26.5¢ paradigm biopharmaceuticals limited..

Aaargh- fascinatin' it'll be indeed in 2-3 months......Voddy be...

First 17 Last

Share
Profile

Follow
Violin1

1,306 Posts.

296

20/07/24

16:26

Post #: 74841368
Share

Originally posted by 39KP: ↑

similar thoughts here JT.

so in one corner we have the 'need a cap raise' as PR can't deliver a deal and we will be diluted into oblivion.

in the other we have the fda go ahead will catalyse a deal with a nice upfront.

time will clearly tell but whilst a cap raise may come I see no credible way to raise their current market cap or more in cash in the foreseeable future, it's just too much. Scott Williams is there for a reason and I would hope / expect the much talked about 32 data room BPs to get more interested once we get an fda go ahead. don't forget about royalty deals etc etc, nor the options funding.

the company has run this far too close for my liking and I'm exhausted by this investment but I trust in the science and in the greed of BP to see a 98% chance of success for a blockbuster drug and start bidding.

personally I'm feeling happy I averaged down in the mid 20s.

it will be a fascinating 2-3 months

Expand

Aaargh- fascinatin' it'll be indeed in 2-3 months......Voddy be drinking rum and we be dancing a gig!!!

PAR Price at posting: 29.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

1 Great analysis

Reply

Top Stories

What's causing the cost-of-living crisis, and how to navigate it

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

First 17 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 26.5¢		Change 0.000(0.00%)		Mkt cap ! $92.81M

Open	High	Low	Value	Volume
27.0¢	29.0¢	25.5¢	$430.3K	1.585M

Buyers (Bids)

No.	Vol.	Price($)
1	5500	26.0¢

Sellers (Offers)

Price($)	Vol.	No.
26.5¢	36162	3

View Market Depth

No.	Vol.	Price($)
3	61837	0.255
2	25200	0.250
1	15000	0.245
3	85000	0.240
1	8510	0.235

Price($)	Vol.	No.
0.265	583	1
0.270	25000	1
0.275	3350	1
0.285	46000	1
0.290	44274	3

Last trade - 16.10pm 18/10/2024 (20 minute delay)

PAR (ASX) Chart